ArticleTrials2024

Low-dose dobutamine in acute myocardial infarction with intermediate to high risk of cardiogenic shock development (the DOBERMANN-D trial): study protocol for a double-blinded, placebo-controlled, single-center, randomized clinical trial.

Sarah Louise Duus Holle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.